Events

Europe’s Green and Digital Transition: The Role of Technology Infrastructures in the new Pact for research and innovation
JUN
Thu
23
09:30 - 15:45

This was 3 years ago

Location

European Commission, Borschette Center, Brussels

Programmes
Research Infrastructures Digital, Industry & Space Climate, Energy, Mobility EIE Enhancing EU R&I

As part of the EU French Council Presidency, the European Commission, the French Alternative Energies and Atomic Energy Commission (CEA) and the European Association of Research and Technology Organisations (EARTO) have organised a high-level conference on "Europe’s Green and Digital Transition: The Role of Technology Infrastructures in the new Pact for Research and Innovation" which will take place on 23 June 2022 in Brussels.

Agenda and registration

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.